Welcome to LeukemiaLinks, your monthly source of leukemia news, research updates, clinical trials and Society events. For even more information, regularly visit the Society's Patient Services and Disease Information Web
pages. |
|
U.S. Experts Support Glaxo's Leukemia Drug Arranon
GlaxoSmithKline's s experimental leukemia and lymphoma drug Arranon (nelarabine) should be granted accelerated U.S. approval for both children and adults, a
U.S. Food and Drug Administration advisory panel has said.
Levofloxacin Prevents Infection in Neutropenic Cancer Patients
Fears of bacterial resistance have generally prevented the prophylactic use of fluoroquinolones in patients with cancer and neutropenia. However, two placebo-controlled clinical trials reported in The New England Journal of Medicine on Sept. 8 show that prophylactic levofloxacin during periods of neutropenia reduces the incidence of febrile episodes and other infection-related outcomes.
Childhood Cancer Survivors Face More Social, School Difficulties
Children who survive cancer are more likely than children without cancer to have social and educational problems as they grow up, according to the first large, nationwide study of the issue published in the journal Cancer. |
|
Childhood Leukemia and Lymphoma: An Update on Current Treatment and Clinical Issues
Join us for this free telephone education program on Wednesday, Sept. 28, 12 noon to 1 p.m. ET. The program will feature Curt Civin, M.D., Sc.D. (honorary),
Samuelson Professor of Oncology and Pediatrics, Johns Hopkins University School of Medicine.
Register online or call (866) 992-9950. Be prepared to include your name, mailing address, telephone number and email address. This program is part of our Focus on Childhood Cancers Educational Series and is sponsored by The Leukemia & Lymphoma Society.
CML Medical Monitor
Find out more about our new CML Medical Monitor, a health tool and educational resource for people living with chronic myeloid leukemia. This tool features a treatment progress tracker to help you monitor your responses to therapies. Based on the data you enter, you can create reports that will help you better understand your condition. The CML Medical Monitor is a secure site, so your information is kept private.
Free Booklets on Leukemia
The Leukemia & Lymphoma Society publishes many educational brochures and pamphlets that are available free to the public. They are designed to provide up-to-date information, in language understandable by the layperson. They can be read online, downloaded or ordered by mail.
The Leukemia & Lymphoma Society is committed to curing blood cancers and helping patients and their families. Learn the many ways you can help advance the Society's mission. |
|
|
|
We invite you to use our Clinical Trial Service, a free and confidential service that can help you find clinical trials that meet your needs. You may also want to visit the National Cancer Institute's Cancer Trials Support Unit, providing resources and information on phase III cancer treatment trials supported by the National Cancer Institute.
Selected Trials
Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes More >
Phase II Study of the Efficacy and Toxicity of Ontak (Denileukin Diftitox) in the Therapy of Adult T-Cell Leukemia More >
Phase III: Induction Therapy Using Cytarabine, Daunorubicin and, Optionally, Gemtuzumab Ozogamicin Followed by Consolidation Therapy with High-Dose Cytarabine and Postconsolidation Therapy with Gemtuzumab Ozogamicin Compared with No Additional Therapy in Patients with Untreated De Novo Acute Myeloid Leukemia More> |
|
Early Molecular Response to Post-Transplantation Imatinib Determines Outcome in MRD+ Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) More >
Synergistic Activity of Imatinib and 17-AAG in Imatinib-Resistant CML Cells Overexpressing BCR-ABL - Inhibition of P-Glycoprotein Function by 17-AAG More >
A Phase I/II trial of Oxidized Autologous Tumor Vaccines During the "Watch and Wait" Phase of Chronic Lymphocytic Leukemia More
> |
|
| Read about a remarkable Hawaii mother who donates her bone marrow to help children sick with leukemia and other blood cancers |
|
| If you haven't found what you're looking for in LeukemiaLinks, please call our Information Resource Center (IRC) to speak with trained information specialists. IRC staff are available Monday through Friday, 9 a.m. to 6 p.m. ET, toll free at (800) 955-4572. You may also email them at [EMAIL PROTECTED] . |
|
|
